Skip to content
Review Open access

Prevalence and predictors of HIV/TB co-infection in Sub-Saharan Africa

Sep 2026 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · Vol 45 · 0 citations · 30 references
Medicine

TL;DR

HIV/TB co-infection remains highly prevalent in SSA, shaped by demographic, socioeconomic, and clinical factors, and tailored HIV/TB interventions are urgently needed through integrated, community-based, and male-friendly care.

Abstract

Background In Sub-Saharan Africa (SSA), tuberculosis is a leading cause of morbidity and mortality among people with HIV (PWH). This study aimed to determine the prevalence of self-reported TB disease and identify the demographic, socioeconomic, and clinical factors associated with it among PWH in SSA. Methods We conducted a cross-sectional secondary analysis of data from the Population-based HIV Impact Assessment (PHIA) surveys (2015–2019), including PWH aged ≥15 years from 13 countries in the SSA region. TB status was self-reported, and standardized questionnaires and biomarker data provided demographic, socioeconomic, and clinical covariates. Logistic regression models were applied using survey weights and jackknife variance estimation to identify predictors of HIV/TB co-infection. Results Among 11,663 participants, 31.5% were people with TB. Co-infection prevalence varied widely by country, ranging from 7.5% in Cameroon to 59.5% in Eswatini, with the highest prevalence observed in Southern African countries. Predictors of increased TB risk include older age [Adjusted (aOR): 1.01; 95% CI: 1.00–1.02; p = 0.012], higher wealth quintile (aOR: 1.09; 95% CI: 1.02–1.16; p < 0.01), and longer ART duration (aOR: 1.41; 95% CI: 1.30–1.52; p < 0.001), while protective factors include female sex (aOR: 0.6; 95% CI: 0.51–0.70; p < 0.001), being married or cohabitating (aOR: 0.81; 95% CI: 0.70–0.96; p = 0.01), urban residence (aOR: 0.82; 95% CI: 0.69–0.98; p = 0.028), and a higher CD4-cell count (aOR: 0.999; 95% CI: 0.998–0.9995; p < 0.001). Conclusions HIV/TB co-infection remains highly prevalent in SSA, shaped by demographic, socioeconomic, and clinical factors. Tailored HIV/TB interventions are urgently needed in SSA, prioritizing Southern and Eastern regions and high-risk groups through integrated, community-based, and male-friendly care. Strengthening health systems, improving diagnostics, and addressing social and structural barriers are critical for equitable, sustained progress.

Read PDF

Similar papers

Review Open access Sep 2026

HIV and Hepatitis B co-infection in Tanzania: Analysis of the 2022–2023 Tanzania HIV Impact Survey

Co-occurrence of HIV and Hepatitis B Virus (HBV) in sub-Saharan Africa, although less prevalent, is often more serious and exhibits rapid clinical deterioration even with appropriate treatment, jeopardizing efforts to reach regional and global targets. Evidence varies in the region and not reported in some countries. W...

F. Mwakasungura, Alfateresia Mwasangama, D. Amani et al. · 0 citations
Open access Sep 2026

Prevalence of HIV and recent infection among people aged 15 to 54 years in post conflict Tigray Ethiopia

A post-war HIV prevalence of 3% in Tigray is demonstrated - three times the epidemic threshold - with a substantial proportion of recent infections, indicating ongoing transmission, and underscores the urgent need for conflict-sensitive HIV prevention strategies and expanded community-based and mobile testing with rapi...

G. Berhe, G. Gebru, M. M. Ebrahim et al. · 0 citations
Open access Jan 2026

Tuberculosis Incidence and Predictors Among People Living With HIV After Isoniazid–Rifapentine (3HP) Preventive Therapy in Ethiopia: A Retrospective Cohort Study

Background Global reports of tuberculosis (TB) in 2024 estimated 10.7 million cases, of which 5.8% were HIV‐positive individuals. Despite the implementation of TB preventive therapy, TB incidence rates remain high, especially among HIV‐infected patients. Methods A retrospective cohort study was conducted from 1 October...

E. Etu, Edao Wajiso Kallo, Kelil Husen Lenbo et al. · 0 citations
Open access Oct 2026

Understanding HIV and Tuberculosis Co-infection: Clinical Outcomes and Population Characteristics

Introduction: Tuberculosis (TB) is one of the most common opportunistic infections and a leading cause of death among people living with HIV (PLHIV). HIV-TB co-infection is a major clinical and public health problem, yet local data on the interval between HIV diagnosis and TB onset, together with antiretroviral (ARV) r...

Rafif Razan Abdillah, R. Setiabudi, M. Rusli et al. · 0 citations
Open access Jan 2026

Prevalence and Correlates of Dyslipidemia in HIV‐Positive Patients at Selected Public Hospitals in Addis Ababa, Ethiopia, 2025

Dyslipidemia was prevalent among approximately two in three HIV‐positive patients receiving long‐term ART at two tertiary hospitals in Addis Ababa, Ethiopia, highlighting the need for routine lipid monitoring and integrated cardiovascular risk management within HIV care settings in similar urban, tertiary‐care contexts...

Nebiat Adane, Mekoya Mengistu, Tariku Fekadu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.